Ustekinumab Linked to More Outpatient Visits and Greater Pharmacy Costs Versus Adalimumab in Psoriasis PatientsMarch 25, 2016Psoriasis
60 weeks of ixekizumab effective, well tolerated in moderate-to-severe plaque psoriasisMarch 10, 2016Psoriasis
Effects of Tumor Necrosis Factor α Inhibitors Extend Beyond Psoriasis: Insulin Sensitivity in Psoriasis Patients With Type 2 Diabetes MellitusMarch 9, 2016Psoriasis
